Johnson Investment Counsel Inc Clearside Biomedical, Inc. Transaction History

Johnson Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.32 - $2.74 $26,400 - $54,800	-20,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.55 - $2.41 $31,000 - $48,200	20,000 New	20,000 $38,000
Q1 2020 May 20, 2020	SELL	$1.32 - $3.77 $26,400 - $75,400	-20,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.59 - $1.32 $11,800 - $26,400	20,000 New	20,000 $13,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $56.6M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.